NASDAQ:AVXL | Free Cash Flow | ANAVEX LIFE SCIENCES CORP.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-09-30 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$7.15M
2025-09-30-$8.6M
2024-12-31-$12.12M
2024-09-30-$6.66M
2023-12-31-$7.32M
2023-09-30-$5.85M
2022-12-31-$5.79M
2022-09-30-$4.04M
2021-12-31-$3.5M
2021-09-30-$7.67M
2020-12-31-$7.87M
2020-09-30-$6.25M
2019-12-31-$5.73M
2019-09-30-$2.53M
2018-12-31-$4.16M
2018-09-30-$4.05M
2017-12-31-$3.62M
2017-09-30-$2.19M
2016-12-31-$3.15M
2016-09-30-$1.86M
2015-12-31-$3.25M
2015-09-30-$1.43M
2014-12-31-$693,070.00
2014-09-30-$916,855.00
2013-12-31-$434,990.00
2013-09-30-$484,508.00
2012-12-31-$131,573.00
2012-09-30-$251,933.00
2011-12-31-$1.09M
2011-09-30-$922,589.00
2010-12-31-$1.08M
2010-09-30-$1.66M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-09-30-$39.04M
2024-09-30-$30.81M
2023-09-30-$27.79M
2022-09-30-$24.24M
2021-09-30-$30.38M
2020-09-30-$21.29M
2019-09-30-$18.53M
2018-09-30-$12.58M
2017-09-30-$9.02M
2016-09-30-$9.24M
2015-09-30-$4.23M
2014-09-30-$2.66M$3,015.00-$2.66M
2013-09-30-$777,573.00
2012-09-30-$1.69M
2011-09-30-$3.8M
2010-09-30-$4.59M